A business in context
LXRX research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-03 | Swain Judith L | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | Swain Judith L | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-06-03 | Sullivan Diane E. | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | Sullivan Diane E. | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-06-03 | SOBECKI CHRISTOPHER J | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | SOBECKI CHRISTOPHER J | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-06-03 | Cheung Ivan | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | Cheung Ivan | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-06-03 | BARKER SAM L | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | BARKER SAM L | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-06-03 | Amouyal Philippe | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | Amouyal Philippe | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-06-03 | DEBBANE RAYMOND | M · Exercise / conversion | Common Stock | 89312.0 | 0.0 |
| 2026-06-03 | DEBBANE RAYMOND | M · Exercise / conversion | Restricted Stock Units | 89312.0 | 0.0 |
| 2026-05-01 | Amouyal Philippe | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | Amouyal Philippe | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-05-01 | SOBECKI CHRISTOPHER J | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-05-01 | SOBECKI CHRISTOPHER J | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | BARKER SAM L | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-05-01 | BARKER SAM L | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | Cheung Ivan | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-05-01 | Cheung Ivan | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | Swain Judith L | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-05-01 | Swain Judith L | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | Sullivan Diane E. | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | Sullivan Diane E. | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-05-01 | DEBBANE RAYMOND | A · Grant / award | Stock Option (Right to Buy) | 43478.0 | 0.0 |
| 2026-05-01 | DEBBANE RAYMOND | A · Grant / award | Restricted Stock Units | 35714.0 | 0.0 |
| 2026-04-30 | Artal Group S.A.; Artal International Management S.A.; Artal International S.C.A.; Artal Participations S.a r.l.; Stichting Administratiekantoor Westend; Westend S.A.; Wittouck Amaury | M · Exercise / conversion | Common Stock | 20421735.0 | 0.0 |
| 2026-04-30 | Artal Group S.A.; Artal International Management S.A.; Artal International S.C.A.; Artal Participations S.a r.l.; Stichting Administratiekantoor Westend; Westend S.A.; Wittouck Amaury | M · Exercise / conversion | Series B Convertible Preferred Stock | 408434.7 | 0.0 |
| 2026-04-30 | Artal Group S.A.; Artal International Management S.A.; Artal International S.C.A.; Artal Participations S.a r.l.; Stichting Administratiekantoor Westend; Westend S.A.; Wittouck Amaury | A · Grant / award | Series B Convertible Preferred Stock | 408434.7 | — |
Identity & relationships
SEC issuer · 0001062822LEXICON PHARMACEUTICALS, INC.
Search names and former names
View Wikidata identity and references ↗
- Lexicon Pharmaceuticals · alias · wikidata
- LEXICON PHARMACEUTICALS, INC./DE · former SEC name · 2007-04-27 to 2014-12-05
- LEXICON GENETICS INC/TX · former SEC name · 2000-03-01 to 2007-04-02
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $31.08M | $33.08M |
| 2023-12-31 | $1.20M | $1.32M |
| 2022-12-31 | $139.0K | $158.6K |
| 2021-12-31 | $298.0K | $367.2K |
| 2020-12-31 | $24.00M | $30.96M |
| 2019-12-31 | $322.07M | $420.64M |
| 2018-12-31 | $63.21M | $84.05M |
| 2017-12-31 | $91.69M | $124.90M |